23.82
price down icon1.45%   -0.285
 
loading
Precedente Chiudi:
$24.11
Aprire:
$24.16
Volume 24 ore:
42,192
Relative Volume:
0.12
Capitalizzazione di mercato:
$165.25M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-14.53
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
-15.54%
1M Prestazione:
-36.57%
6M Prestazione:
+79.62%
1 anno Prestazione:
+47.61%
Intervallo 1D:
Value
$23.50
$24.50
Intervallo di 1 settimana:
Value
$23.12
$28.66
Portata 52W:
Value
$2.622
$65.80

Vor Biopharma Inc Stock (VOR) Company Profile

Name
Nome
Vor Biopharma Inc
Name
Telefono
617-655-6580
Name
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Name
Dipendente
168
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
VOR's Discussions on Twitter

Confronta VOR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VOR
Vor Biopharma Inc
23.82 165.25M 0 -112.46M -99.89M -1.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.52 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
635.18 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
441.68 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
827.86 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.35 40.44B 447.02M -1.18B -868.57M -6.1812

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-15 Aggiornamento Robert W. Baird Neutral → Outperform
2025-09-24 Aggiornamento Stifel Hold → Buy
2025-06-30 Aggiornamento H.C. Wainwright Neutral → Buy
2022-07-26 Iniziato Wedbush Outperform
2022-04-27 Iniziato Goldman Neutral
2021-12-17 Iniziato H.C. Wainwright Buy
2021-12-03 Iniziato Robert W. Baird Outperform
2021-12-02 Iniziato Oppenheimer Outperform
2021-10-19 Iniziato JMP Securities Mkt Outperform
2021-03-25 Iniziato B. Riley Securities Buy
2021-03-03 Iniziato Barclays Overweight
2021-03-03 Iniziato Evercore ISI Outperform
2021-03-02 Iniziato Goldman Sell
2021-03-02 Iniziato Stifel Buy
Mostra tutto

Vor Biopharma Inc Borsa (VOR) Ultime notizie

pulisher
08:32 AM

Vor Biopharma Appoints New Chief Medical Officer - TipRanks

08:32 AM
pulisher
08:00 AM

Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - GlobeNewswire

08:00 AM
pulisher
05:09 AM

Forecasting Vor Biopharma Inc. price range with options dataMarket Trend Review & Risk Managed Investment Strategies - newser.com

05:09 AM
pulisher
04:21 AM

Technical signs of recovery in Vor Biopharma Inc.July 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com

04:21 AM
pulisher
03:42 AM

Vor Biopharma Inc. stock retracement – recovery analysis2025 Historical Comparison & Momentum Based Trading Signals - newser.com

03:42 AM
pulisher
03:39 AM

Risk adjusted return profile for Vor Biopharma Inc. analyzedJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com

03:39 AM
pulisher
02:43 AM

Vor Biopharma Inc. stock volume spike explainedVolume Spike & Community Trade Idea Sharing - newser.com

02:43 AM
pulisher
02:33 AM

Will Vor Biopharma Inc. stock gain from government policiesQuarterly Profit Report & Real-Time Stock Movement Alerts - newser.com

02:33 AM
pulisher
Nov 02, 2025

Long term hold vs stop loss in Vor Biopharma Inc.Weekly Trend Recap & Fast Entry Momentum Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Applying big data sentiment scoring on Vor Biopharma Inc.Day Trade & Weekly Market Pulse Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Vor Biopharma Inc. stock chart pattern explainedJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How currency fluctuations impact Vor Biopharma Inc. stockWeekly Investment Recap & Smart Money Movement Tracker - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using data models to predict Vor Biopharma Inc. stock movementWeekly Risk Report & Weekly Stock Performance Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Pattern recognition hints at Vor Biopharma Inc. upsideQuarterly Portfolio Report & Long-Term Safe Return Strategies - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 01:05:22 - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Q3 EPS Estimates for Vor Biopharma Boosted by HC Wainwright - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Combining price and volume data for Vor Biopharma Inc.Weekly Loss Report & Weekly Watchlist of Top Performers - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Can Vor Biopharma Inc. stock resist sector downturnsCPI Data & Daily Profit Maximizing Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 124,311 Shares - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 251,518 Shares - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Vor Biopharma Inc. - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Vor Bio (NASDAQ: VOR) issues inducement equity to 20 new hires at $30.22 per share - Stock Titan

Oct 31, 2025
pulisher
Oct 31, 2025

FY2028 EPS Estimates for Vor Biopharma Decreased by Analyst - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:21:03 - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million By Investing.com - Investing.com Nigeria

Oct 30, 2025
pulisher
Oct 30, 2025

Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million - Investing.com

Oct 30, 2025
pulisher
Oct 30, 2025

VOR Form 4: RA Capital reports multi-day insider stock sales - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Vor Biopharma Inc. (VOR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Vor Biopharma (NASDAQ:VOR) Price Target Raised to $52.00 - MarketBeat

Oct 30, 2025
pulisher
Oct 29, 2025

Can Vor Biopharma Inc. stock maintain operating marginsWeekly Investment Report & Verified Entry Point Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Vor Biopharma (VOR) Price Target Increased by 30.77% to 47.68 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Vor Biopharma (VOR) Stock Target Price Raised by HC Wainwright & - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Vor Biopharma Says Telitacicept Sustains Efficacy in Phase 3 Myasthenia Gravis Trial in China - MarketScreener

Oct 29, 2025

Vor Biopharma Inc Azioni (VOR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Vor Biopharma Inc Azioni (VOR) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 28 '25
Sale
27.42
124,311
3,408,230
1,055,749
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 30 '25
Sale
25.12
24,579
617,424
779,652
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 27 '25
Sale
28.12
90,941
2,557,261
1,180,060
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 23 '25
Sale
28.01
76,880
2,153,409
1,324,346
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 24 '25
Sale
28.01
53,345
1,494,193
1,271,001
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 20 '25
Sale
29.67
92,023
2,730,483
0
RA CAPITAL MANAGEMENT, L.P.
Director
Oct 21 '25
Sale
28.11
25,027
703,509
1,401,226
Reprogrammed Interchange LLC
10% Owner
Oct 17 '25
Sale
30.25
25,717
777,987
1,178,725
Reprogrammed Interchange LLC
10% Owner
Oct 20 '25
Sale
30.05
11,616
349,101
1,167,109
Reprogrammed Interchange LLC
10% Owner
Oct 21 '25
Sale
30.07
200
6,015
1,166,909
$37.33
price down icon 0.21%
$92.90
price down icon 0.29%
$28.82
price up icon 0.74%
$104.39
price up icon 0.46%
biotechnology ONC
$312.52
price up icon 0.95%
$182.24
price down icon 3.63%
Capitalizzazione:     |  Volume (24 ore):